Anzeige
Mehr »
Login
Samstag, 02.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Technischer Ausbruch: Diese Kupferaktie ist in den letzten 52 Wochen um 300 % gestiegen! Der Durchbruch läuft!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DU6V | ISIN: US1897631057 | Ticker-Symbol: C97
Tradegate
30.10.24
18:36 Uhr
1,110 Euro
-0,010
-0,89 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
CO-DIAGNOSTICS INC Chart 1 Jahr
5-Tage-Chart
CO-DIAGNOSTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,0801,14013:05
1,0801,15001.11.

Aktuelle News zur CO-DIAGNOSTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
31.08.Co-Diagnostics sees shareholder backing in annual meeting votes3
30.08.Co-Diagnostics, Inc. - 8-K, Current Report1
13.08.Co-Diagnostics stock target cut by H.C. Wainwright13
08.08.Co-Diagnostics, Inc. - 10-Q, Quarterly Report1
08.08.Co-Diagnostics, Inc. - 8-K, Current Report1
08.08.Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Results136SALT LAKE CITY, August 8, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic...
► Artikel lesen
07.08.Co-Diagnostics Inc expected to post a loss of 34 cents a share - Earnings Preview1
14.06.Co-Diagnostics, Inc. - 8-K, Current Report4
10.05.Earnings call: Co-Diagnostics Q1 2024 financial results and updates8
10.05.Co-Diagnostics, Inc. (CODX) Q1 2024 Earnings Call Transcript4
09.05.Co-Diagnostics, Inc. - 10-Q, Quarterly Report1
09.05.Co-Diagnostics, Inc. - 8-K, Current Report1
09.05.Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results779SALT LAKE CITY, May 9, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Dx," or the "Company"), a molecular diagnostics company with a unique, patented platform for the development...
► Artikel lesen
14.03.Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results1.101SALT LAKE CITY, March 14, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic...
► Artikel lesen
07.03.Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test358The clinical laboratory real-time PCR multiplex test was designed using Co-Dx Co-Primers and licensed by the CDSCO for use in diagnostic procedures SALT LAKE CITY, March 7, 2024 /PRNewswire/ --...
► Artikel lesen
09.11.23Co-Diagnostics, Inc. Reports Third Quarter 2023 Financial Results236Receives grant award from the Bill & Melinda Gates Foundation in the amount of $9.0M for the development of tuberculosis test on Co-Dx PCR platform. SALT LAKE CITY, Nov. 9, 2023 /PRNewswire/ --...
► Artikel lesen
16 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1